Close Menu

    Subscribe to Updates

    Get the latest creative news from Healthradar about News,Health and Gadgets.

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    What's Hot

    Eko Health Appoints Dr. Jerome Adams as Distinguished Medical Advisor

    23. August 2025

    Charlie Health Expands Virtual Behavioral Healthcare to Ages 8-64

    23. August 2025

    Another major medical association breaks from CDC as ob/gyn group recommends Covid-19 vaccines during pregnancy

    23. August 2025
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram Pinterest Vimeo
    healthradar.nethealthradar.net
    • Home
    • Ai
    • Gadgets
    • Health
    • News
    • Contact Us
    Contact
    healthradar.nethealthradar.net
    Home»News»Stryker lowers expected tariff impact to $175M
    News

    Stryker lowers expected tariff impact to $175M

    HealthradarBy Healthradar1. August 2025Keine Kommentare3 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Reddit Telegram Email
    Stryker lowers expected tariff impact to 5M
    Share
    Facebook Twitter LinkedIn Pinterest Email


    This audio is auto-generated. Please let us know if you have feedback.

    By the numbers

     

    Q2 revenue: $6 billion

    11.1% increase year over year

     

    Net income: $884 million

    7.2% increase year over year

    Stryker expects a $175 million tariff impact on earnings in 2025, a slight decrease from the $200 million the company forecast in May. Stryker joins several medical device companies that have slashed tariff expectations, with several firms, including Johnson & Johnson and Boston Scientific, cutting the expected tariff hit by as much as half. 

    Stryker CFO Preston Wells said Thursday on an earnings call that the changes were a result of the U.S. and China agreeing to significantly reduce levies. However, Stryker did not cut its forecast by as much as other companies because the recent trade agreement with the European Union, which set a tariff rate of 15%, was more than the 10% Stryker had included in its previous model.

    CEO Kevin Lobo said Stryker was impacted less than other companies due to its manufacturing footprint in Europe and having less of a presence in China than other medtech companies.

    Raised earnings forecast

    Stryker raised its financial forecast for the year, now expecting organic sales growth in a range of 9.5% to 10%, from a previous range of 8.5% to 9.5%. The company also raised its expectations for adjusted earnings per share by about 20 cents. 

    Lobo said the update was driven by continued procedural strength, including implants, and demand for capital equipment. Wells said initiatives Stryker started during the COVID-19 pandemic, such as pricing and manufacturing efficiency, have helped drive margin improvements. 

    Robot update

    Stryker shared an update on planned launches for the company’s robots. In March, the company unveiled its latest orthopedic robot, the Mako 4. The Food and Drug Administration cleared the new system, but Stryker has not yet rolled out the robot globally, Lobo said.

    The company has new hip revision and spine surgery applications that are only available on Mako 4. Stryker’s shoulder surgery application is currently on its Mako 3 robot, and is in the process of migrating to the newer robot, Lobo said. Because of that, the feature is still in a limited launch until next year. 

    Stryker reported a record quarter for Mako installations, although the company did not disclose the number of robots. The company reached a milestone of 2 million robotic procedures performed with Mako during the second quarter.



    Source link

    175M expected Impact lowers Stryker tariff
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleScientists found that animal fats – butter, lard and beef tallow – impair the immune system’s response to tumors, however, plant-based fats like palm, coconut, and olive oil don’t, finds a new landmark study in mice. And some of these may even help in the fight.
    Next Article MAGENTIQ EYE Secures Funding to Advance AI-Powered Gastroenterology Diagnostics
    ekass777x
    Healthradar
    • Website

    Related Posts

    News

    Charlie Health Expands Virtual Behavioral Healthcare to Ages 8-64

    23. August 2025
    News

    Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

    22. August 2025
    News

    The robotic surgery market battle is heating up

    22. August 2025
    Add A Comment
    Leave A Reply Cancel Reply

    Top Posts

    Garmin Venu 4: Everything we know so far about the premium smartwatch

    7. August 202534 Views

    Linea Expands AI-Powered Heart Failure Care Solution

    6. August 202518 Views

    The Top 3 Tax Mistakes High-Earning Physicians Make

    7. August 202515 Views

    Neurode wants to treat and track ADHD symptoms through a wearable headband

    1. Juni 20259 Views
    Stay In Touch
    • Facebook
    • YouTube
    • TikTok
    • WhatsApp
    • Twitter
    • Instagram
    Latest Reviews

    Subscribe to Updates

    Bitte aktiviere JavaScript in deinem Browser, um dieses Formular fertigzustellen.
    Wird geladen
    About Us

    Welcome to HealthRadar.net — your trusted destination for discovering the latest innovations in digital health. We are dedicated to connecting individuals, healthcare professionals, and organizations with cutting-edge tools, applications

    Most Popular

    Garmin Venu 4: Everything we know so far about the premium smartwatch

    7. August 202534 Views

    Linea Expands AI-Powered Heart Failure Care Solution

    6. August 202518 Views
    USEFULL LINK
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    QUICK LINKS
    • Ai
    • Gadgets
    • Health
    • News
    • About Us
    • Contact Us
    • Disclaimer
    • Privacy Policy
    Copyright© 2025 Healthradar All Rights Reserved.

    Type above and press Enter to search. Press Esc to cancel.